Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-12

Clinical Trial Update: Platelet Rich Plasma Combined With Human Umbilical Cord Mesenchymal Stem Cells for Stage 3 and 4 Stress Injury [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial evaluating platelet-rich plasma combined with human umbilical cord mesenchymal stem cells for advanced pressure injuries (Stage 3 and Stage 4). S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma + human umbilical cord mesenchymal stem cells

Snippet

Sponsor: Liaocheng People's Hospital | Conditions: Pressure Injuries - Stage 3, Pressure Injuries - Stage 4 | Phase 1, Phase 2 | Status: UNKNOWN